Billiontoone (NASDAQ:BLLN) Shares Gap Down Following Insider Selling

Shares of Billiontoone, Inc. (NASDAQ:BLLN) gapped down before the market opened on Thursday following insider selling activity. The stock had previously closed at $149.97, but opened at $105.16. Billiontoone shares last traded at $94.4910, with a volume of 803,215 shares traded.

Specifically, CEO Oguzhan Atay sold 12,500 shares of the company’s stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $137.37, for a total value of $1,717,125.00. Following the transaction, the chief executive officer directly owned 162,500 shares of the company’s stock, valued at $22,322,625. This represents a 7.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 32,500 shares of the stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $136.95, for a total value of $4,450,875.00. Following the completion of the transaction, the chief executive officer owned 20,000 shares in the company, valued at $2,739,000. This represents a 61.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In related news, insider Shan Riku Sakakibara sold 4,000 shares of the company’s stock in a transaction on Friday, July 31st. The shares were sold at an average price of $140.21, for a total value of $560,840.00. Following the completion of the sale, the insider directly owned 200,000 shares in the company, valued at approximately $28,042,000. This represents a 1.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Analyst Ratings Changes

BLLN has been the subject of a number of recent analyst reports. Guggenheim assumed coverage on Billiontoone in a research report on Monday, June 29th. They set a “buy” rating and a $125.00 target price for the company. JPMorgan Chase & Co. upped their price target on shares of Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Weiss Ratings raised Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. Finally, BTIG Research dropped their price target on Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday. Six analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $126.00.

Key Headlines Impacting Billiontoone

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: BTIG Research maintained a Buy rating while lowering its price target from $142 to $130. The revised target still implies approximately 31% upside from the referenced share price, indicating the firm views the recent weakness as a buying opportunity. Benzinga analyst price target report
• Positive Sentiment: BillionToOne reported second-quarter EPS of $0.15, matching Wall Street expectations, and revenue of $109.45 million. The company also reiterated full-year 2026 revenue guidance of $450 million to $465 million, broadly consistent with the $453.3 million analyst consensus. BillionToOne second-quarter 2026 results
• Neutral Sentiment: The earnings release did not provide a clearly positive guidance increase, and the reported quarter met rather than exceeded expectations. With the stock trading at a high valuation, investors may have been looking for a stronger beat or upward revision to forecasts.
• Negative Sentiment: CEO Oguzhan Atay sold a combined 45,000 shares for approximately $6.17 million, reducing his holdings substantially. Although both transactions were executed under a pre-arranged Rule 10b5-1 plan, the size of the sales may weigh on sentiment. SEC filing for CEO stock sales
• Negative Sentiment: Insider Shan Riku Sakakibara separately sold 4,000 shares worth about $561,000. The sale was also pre-arranged, but it adds to a recent pattern of insider selling and may reinforce profit-taking concerns after BLLN’s strong run.
• Negative Sentiment: BTIG’s price-target reduction, despite its continued Buy rating, signals that the firm has moderated its near-term valuation expectations. This is particularly relevant as BillionToOne’s elevated price-to-earnings multiple leaves the stock sensitive to any sign of slowing growth or limited upside revisions.

Billiontoone Price Performance

The company has a 50-day moving average of $116.73 and a 200 day moving average of $94.26. The company has a debt-to-equity ratio of 0.18, a quick ratio of 10.58 and a current ratio of 10.92. The firm has a market cap of $4.38 billion and a P/E ratio of 172.72.

Billiontoone (NASDAQ:BLLN) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.15. The company had revenue of $109.45 million for the quarter. On average, sell-side analysts anticipate that Billiontoone, Inc. will post 0.92 EPS for the current year.

Hedge Funds Weigh In On Billiontoone

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA bought a new position in shares of Billiontoone in the fourth quarter valued at approximately $13,373,000. Baillie Gifford & Co. bought a new stake in shares of Billiontoone during the fourth quarter worth $103,786,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Billiontoone in the fourth quarter valued at $1,348,000. UBS Group AG bought a new stake in Billiontoone during the 4th quarter worth about $2,586,000. Finally, Renaissance Capital LLC bought a new position in shares of Billiontoone in the fourth quarter worth about $201,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.